Of the 300 patients in the PARCER trial, 93 faced grades ≥2 adverse events (3D-CRT = 59, IG-IMRT = 34). Patients in the 3D-CRT and IG-IMRT arms spent an average of 2.39 years and 1.96 years in ...
Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country Setting The average time to manually develop treatment plans was 7 ...
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative ...
Advances in cancer therapies continue to improve survival rates for patients with overall cancer death rates from 2013-2017 decreasing for men, women, children, and adolescents and young adults, ...
PHILADELPHIA, PA – Secondary analysis results from the phase III NRG Oncology-RTOG 0617 clinical trial comparing standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable ...
Mack Roach III, MD, professor of radiation oncology and urology, has been named chair of the Department of Radiation Oncology. "Dr. Roach is recognized as one of America's leading authorities on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results